Catalyst Wire Dossier Catalyst Wire Dossier

Atezolizumab (Tecentriq)

atezolizumab · Genentech (Roche)
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Atezolizumab (Tecentriq), covering 2024-11-01 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial [Phase 2, Phase 3]

See pricing